Ikena Oncology Ownership 2024 | Who Owns Ikena Oncology Now?
Institutional Ownership
15.94%
Insider Ownership
7.00%
Retail Ownership
77.06%
Institutional Holders
19.00
Ikena Oncology Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC | 10.40% | 0.87% | 5,018,178 | - | - | 8,279,994 | Jun 30, 2024 |
| BVF INC/IL | 9.88% | 0.22% | 4,769,164 | - | - | 7,869,121 | Jun 30, 2024 |
| BLUE OWL CAPITAL HOLDINGS LP | 8.48% | 1.88% | 4,091,118 | 200,000 | 5.14% | 6,750,345 | Jun 30, 2024 |
| ORBIMED ADVISORS LLC | 7.33% | 0.12% | 3,539,358 | - | - | 5,839,941 | Jun 30, 2024 |
| OMEGA FUND MANAGEMENT, LLC | 4.66% | 2.75% | 2,249,123 | - | - | 3,711,053 | Jun 30, 2024 |
| VANGUARD GROUP INC | 2.83% | - | 1,364,470 | -167,699 | -10.95% | 2,251,376 | Jun 30, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 2.05% | 0.00% | 987,900 | 700,000 | 243.14% | 1,630,035 | Jun 30, 2024 |
| BML CAPITAL MANAGEMENT, LLC | 1.21% | 0.69% | 585,114 | 585,114 | 100.00% | 965,438 | Jun 30, 2024 |
| NEA MANAGEMENT COMPANY, LLC | 1.18% | 0.07% | 570,050 | - | - | 940,583 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.99% | 0.00% | 476,400 | -300,200 | -38.66% | 786,060 | Jun 30, 2024 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 0.88% | 0.00% | 424,377 | -89,063 | -17.35% | 700,222 | Jun 30, 2024 |
| ACUITAS INVESTMENTS, LLC | 0.83% | 0.35% | 399,879 | 2,133 | 0.54% | 659,800 | Jun 30, 2024 |
| SOFINNOVA INVESTMENTS, INC. | 0.79% | 0.03% | 382,616 | - | - | 631,316 | Jun 30, 2024 |
| BLACKROCK INC. | 0.74% | - | 354,842 | -1,473,910 | -80.60% | 585,489 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.73% | 0.00% | 354,710 | 354,710 | 100.00% | 585,272 | Jun 30, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | 0.67% | 0.00% | 325,713 | 42,931 | 15.18% | 536,000 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 0.57% | 0.00% | 273,834 | 201,237 | 277.20% | 451,827 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.53% | - | 256,707 | -340,570 | -57.02% | 423,669 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.49% | 0.00% | 236,878 | -6,082 | -2.50% | 390,849 | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.45% | 0.00% | 216,851 | -17,418 | -7.43% | 357,804,000 | Jun 30, 2024 |
Ikena Oncology's largest institutional shareholder is ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC, holding 10.40% of the company's total share outstanding, currently valued at $8.28M. The top 10 institutional shareholders own together 49.01% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| OMEGA FUND MANAGEMENT, LLC | 4.66% | 2.75% | 2,249,123 | - | - | 3,711,053 | Jun 30, 2024 |
| BLUE OWL CAPITAL HOLDINGS LP | 8.48% | 1.88% | 4,091,118 | 200,000 | 5.14% | 6,750,345 | Jun 30, 2024 |
| ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC | 10.40% | 0.87% | 5,018,178 | - | - | 8,279,994 | Jun 30, 2024 |
| BML CAPITAL MANAGEMENT, LLC | 1.21% | 0.69% | 585,114 | 585,114 | 100.00% | 965,438 | Jun 30, 2024 |
| ACUITAS INVESTMENTS, LLC | 0.83% | 0.35% | 399,879 | 2,133 | 0.54% | 659,800 | Jun 30, 2024 |
| DEUTERIUM CAPITAL MANAGEMENT, LLC | 0.17% | 0.22% | 80,578 | 80,578 | 100.00% | 132,954 | Jun 30, 2024 |
| BVF INC/IL | 9.88% | 0.22% | 4,769,164 | - | - | 7,869,121 | Jun 30, 2024 |
| ORBIMED ADVISORS LLC | 7.33% | 0.12% | 3,539,358 | - | - | 5,839,941 | Jun 30, 2024 |
| NEA MANAGEMENT COMPANY, LLC | 1.18% | 0.07% | 570,050 | - | - | 940,583 | Jun 30, 2024 |
| SOFINNOVA INVESTMENTS, INC. | 0.79% | 0.03% | 382,616 | - | - | 631,316 | Jun 30, 2024 |
| MARQUETTE ASSET MANAGEMENT, LLC | 0.15% | 0.02% | 72,890 | - | - | 120,269 | Jun 30, 2024 |
| ALPINE GLOBAL MANAGEMENT, LLC | 0.13% | 0.02% | 64,641 | 64,641 | 100.00% | 106,658 | Jun 30, 2024 |
| JBF CAPITAL, INC. | 0.15% | 0.02% | 72,647 | 72,647 | 100.00% | 119,867 | Jun 30, 2024 |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | 0.09% | 0.02% | 45,520 | 45,520 | 100.00% | 75,108 | Jun 30, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | 0.10% | 0.01% | 46,685 | 11,685 | 33.39% | 77,030 | Jun 30, 2024 |
| CORSAIR CAPITAL MANAGEMENT, L.P. | 0.05% | 0.01% | 24,830 | 24,830 | 100.00% | 40,970 | Jun 30, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | 0.13% | 0.01% | 60,628 | 60,628 | 100.00% | 100,036 | Jun 30, 2024 |
| VIRTU FINANCIAL LLC | 0.06% | 0.00% | 28,053 | 28,053 | 100.00% | 46,000 | Jun 30, 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.17% | 0.00% | 82,300 | - | - | 135,795 | Jun 30, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 2.05% | 0.00% | 987,900 | 700,000 | 243.14% | 1,630,035 | Jun 30, 2024 |
The largest Ikena Oncology shareholder by % of total assets is OMEGA FUND MANAGEMENT, LLC. The company owns 2.25M shares of Ikena Oncology (IKNA), representing 2.75% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 2.05% | 0.00% | 987,900 | 700,000 | 243.14% | 1,630,035 | Jun 30, 2024 |
| BML CAPITAL MANAGEMENT, LLC | 1.21% | 0.69% | 585,114 | 585,114 | 100.00% | 965,438 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.73% | 0.00% | 354,710 | 354,710 | 100.00% | 585,272 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 0.57% | 0.00% | 273,834 | 201,237 | 277.20% | 451,827 | Jun 30, 2024 |
| BLUE OWL CAPITAL HOLDINGS LP | 8.48% | 1.88% | 4,091,118 | 200,000 | 5.14% | 6,750,345 | Jun 30, 2024 |
| DEUTERIUM CAPITAL MANAGEMENT, LLC | 0.17% | 0.22% | 80,578 | 80,578 | 100.00% | 132,954 | Jun 30, 2024 |
| CENTIVA CAPITAL, LP | 0.15% | 0.00% | 73,431 | 73,431 | 100.00% | 121,161 | Jun 30, 2024 |
| JBF CAPITAL, INC. | 0.15% | 0.02% | 72,647 | 72,647 | 100.00% | 119,867 | Jun 30, 2024 |
| ALPINE GLOBAL MANAGEMENT, LLC | 0.13% | 0.02% | 64,641 | 64,641 | 100.00% | 106,658 | Jun 30, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | 0.13% | 0.01% | 60,628 | 60,628 | 100.00% | 100,036 | Jun 30, 2024 |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | 0.09% | 0.02% | 45,520 | 45,520 | 100.00% | 75,108 | Jun 30, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | 0.67% | 0.00% | 325,713 | 42,931 | 15.18% | 536,000 | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 0.07% | 0.00% | 34,941 | 34,941 | 100.00% | 57,652 | Jun 30, 2024 |
| PALOMA PARTNERS MANAGEMENT CO | 0.06% | 0.00% | 30,240 | 30,240 | 100.00% | 49,896 | Jun 30, 2024 |
| VIRTU FINANCIAL LLC | 0.06% | 0.00% | 28,053 | 28,053 | 100.00% | 46,000 | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | 0.06% | 0.00% | 27,666 | 27,666 | 100.00% | 45,649 | Jun 30, 2024 |
| HRT FINANCIAL LP | 0.06% | 0.00% | 26,893 | 26,893 | 100.00% | 44,000 | Jun 30, 2024 |
| CORSAIR CAPITAL MANAGEMENT, L.P. | 0.05% | 0.01% | 24,830 | 24,830 | 100.00% | 40,970 | Jun 30, 2024 |
| AQR CAPITAL MANAGEMENT LLC | 0.05% | 0.00% | 21,861 | 21,861 | 100.00% | 36,071 | Jun 30, 2024 |
| BERKSHIRE ASSET MANAGEMENT LLC/PA | 0.04% | 0.00% | 20,000 | 20,000 | 100.00% | 33,000 | Jun 30, 2024 |
As of Jun 30 2024, Ikena Oncology's largest institutional buyer is ADAGE CAPITAL PARTNERS GP, L.L.C.. The company purchased 700.00K stocks of IKNA, valued at $1.63M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BLACKROCK INC. | 0.74% | - | 354,842 | -1,473,910 | -80.60% | 585,489 | Jun 30, 2024 |
| VERITION FUND MANAGEMENT LLC | 0.28% | 0.00% | 135,297 | -999,390 | -88.08% | 223,240 | Jun 30, 2024 |
| STATE STREET CORP | 0.17% | - | 80,353 | -402,292 | -83.35% | 132,582,000 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.53% | - | 256,707 | -340,570 | -57.02% | 423,669 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.99% | 0.00% | 476,400 | -300,200 | -38.66% | 786,060 | Jun 30, 2024 |
| VANGUARD GROUP INC | 2.83% | - | 1,364,470 | -167,699 | -10.95% | 2,251,376 | Jun 30, 2024 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 0.88% | 0.00% | 424,377 | -89,063 | -17.35% | 700,222 | Jun 30, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.03% | - | 12,066 | -73,880 | -85.96% | 19,909 | Jun 30, 2024 |
| BANK OF NEW YORK MELLON CORP | - | - | - | -70,940 | -100.00% | - | Jun 30, 2024 |
| MARSHALL WACE, LLP | 0.09% | 0.00% | 44,933 | -43,758 | -49.34% | 74,140 | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | - | - | - | -36,322 | -100.00% | - | Jun 30, 2024 |
| CORNERCAP INVESTMENT COUNSEL INC | - | - | - | -36,157 | -100.00% | - | Jun 30, 2024 |
| RHUMBLINE ADVISERS | 0.01% | - | 3,856 | -23,957 | -86.14% | 6,362 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.00% | - | 327 | -18,899 | -98.30% | 539 | Jun 30, 2024 |
| XTX TOPCO LTD | 0.03% | 0.00% | 16,607 | -18,665 | -52.92% | 27,402 | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.45% | 0.00% | 216,851 | -17,418 | -7.43% | 357,804,000 | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -15,255 | -100.00% | - | Jun 30, 2024 |
| NEW YORK STATE COMMON RETIREMENT FUND | - | - | - | -14,992 | -100.00% | - | Jun 30, 2024 |
| ENSIGN PEAK ADVISORS, INC | - | - | - | -13,794 | -100.00% | - | Jun 30, 2024 |
| JPMORGAN CHASE & CO | 0.00% | - | 849 | -12,492 | -93.64% | 1,401 | Jun 30, 2024 |
As of Jun 30 2024, Ikena Oncology's biggest institutional seller is BLACKROCK INC.. The company sold -1.47M shares of IKNA, valued at $585.49K.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BML CAPITAL MANAGEMENT, LLC | 1.21% | 0.69% | 585,114 | 585,114 | 100.00% | 965,438 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.73% | 0.00% | 354,710 | 354,710 | 100.00% | 585,272 | Jun 30, 2024 |
| DEUTERIUM CAPITAL MANAGEMENT, LLC | 0.17% | 0.22% | 80,578 | 80,578 | 100.00% | 132,954 | Jun 30, 2024 |
| CENTIVA CAPITAL, LP | 0.15% | 0.00% | 73,431 | 73,431 | 100.00% | 121,161 | Jun 30, 2024 |
| JBF CAPITAL, INC. | 0.15% | 0.02% | 72,647 | 72,647 | 100.00% | 119,867 | Jun 30, 2024 |
| ALPINE GLOBAL MANAGEMENT, LLC | 0.13% | 0.02% | 64,641 | 64,641 | 100.00% | 106,658 | Jun 30, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | 0.13% | 0.01% | 60,628 | 60,628 | 100.00% | 100,036 | Jun 30, 2024 |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | 0.09% | 0.02% | 45,520 | 45,520 | 100.00% | 75,108 | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 0.07% | 0.00% | 34,941 | 34,941 | 100.00% | 57,652 | Jun 30, 2024 |
| PALOMA PARTNERS MANAGEMENT CO | 0.06% | 0.00% | 30,240 | 30,240 | 100.00% | 49,896 | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | 0.06% | 0.00% | 27,666 | 27,666 | 100.00% | 45,649 | Jun 30, 2024 |
| HRT FINANCIAL LP | 0.06% | 0.00% | 26,893 | 26,893 | 100.00% | 44,000 | Jun 30, 2024 |
| CORSAIR CAPITAL MANAGEMENT, L.P. | 0.05% | 0.01% | 24,830 | 24,830 | 100.00% | 40,970 | Jun 30, 2024 |
| AQR CAPITAL MANAGEMENT LLC | 0.05% | 0.00% | 21,861 | 21,861 | 100.00% | 36,071 | Jun 30, 2024 |
| BERKSHIRE ASSET MANAGEMENT LLC/PA | 0.04% | 0.00% | 20,000 | 20,000 | 100.00% | 33,000 | Jun 30, 2024 |
| BBR PARTNERS, LLC | 0.04% | 0.00% | 20,000 | 20,000 | 100.00% | 33,000 | Jun 30, 2024 |
| VANGUARD PERSONALIZED INDEXING MANAGEMENT, LLC | 0.04% | 0.00% | 18,310 | 18,310 | 100.00% | 30,212 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.03% | 0.00% | 16,270 | 16,270 | 100.00% | 26,846 | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 0.01% | 0.00% | 4,842 | 4,842 | 100.00% | 7,989 | Jun 30, 2024 |
| POINT72 (DIFC) LTD | 0.01% | 0.00% | 4,392 | 4,392 | 100.00% | 7,247 | Jun 30, 2024 |
| RUSSELL INVESTMENTS GROUP, LTD. | 0.00% | - | 2,316 | 2,316 | 100.00% | 3,821 | Jun 30, 2024 |
| MACQUARIE GROUP LTD | 0.00% | - | 1,585 | 1,585 | 100.00% | 2,615 | Jun 30, 2024 |
| CWM, LLC | 0.00% | - | 985 | 985 | 100.00% | 2,000 | Jun 30, 2024 |
| SRS CAPITAL ADVISORS, INC. | 0.00% | - | 299 | 299 | 100.00% | 494 | Jun 30, 2024 |
| NISA INVESTMENT ADVISORS, LLC | 0.00% | - | 99 | 99 | 100.00% | 163 | Jun 30, 2024 |
Ikena Oncology's largest new institutional shareholder by number of shares is BML CAPITAL MANAGEMENT, LLC, purchased 585.11K shares, valued at $965.44K, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BANK OF NEW YORK MELLON CORP | - | - | - | -70,940 | -100.00% | - | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | - | - | - | -36,322 | -100.00% | - | Jun 30, 2024 |
| CORNERCAP INVESTMENT COUNSEL INC | - | - | - | -36,157 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -15,255 | -100.00% | - | Jun 30, 2024 |
| NEW YORK STATE COMMON RETIREMENT FUND | - | - | - | -14,992 | -100.00% | - | Jun 30, 2024 |
| ENSIGN PEAK ADVISORS, INC | - | - | - | -13,794 | -100.00% | - | Jun 30, 2024 |
| SG AMERICAS SECURITIES, LLC | - | - | - | -12,490 | -100.00% | - | Jun 30, 2024 |
| WELLS FARGO & COMPANY/MN | - | - | - | -10,880 | -100.00% | - | Jun 30, 2024 |
| INVESCO LTD. | - | - | - | -10,158 | -100.00% | - | Jun 30, 2024 |
| ATOM INVESTORS LP | - | - | - | -10,155 | -100.00% | - | Jun 30, 2024 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | - | - | - | -3,515 | -100.00% | - | Jun 30, 2024 |
| LEGAL & GENERAL GROUP PLC | - | - | - | -2,045 | -100.00% | - | Jun 30, 2024 |
| AMERITAS INVESTMENT PARTNERS, INC. | - | - | - | -1,755 | -100.00% | - | Jun 30, 2024 |
| AMALGAMATED BANK | - | - | - | -717 | -100.00% | - | Jun 30, 2024 |
| ROYAL BANK OF CANADA | - | - | - | -707 | -100.00% | - | Jun 30, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | - | -3 | -100.00% | - | Jun 30, 2024 |
Ikena Oncology's largest sold out institutional shareholder by shares sold is BANK OF NEW YORK MELLON CORP, sold -70.94K shares, valued at -, as of undefined.
Ikena Oncology Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| CORNERCAP GROUP OF FUNDS /VA/ | 0.16% | 11,876 | - | - | Sep 30, 2022 |
| FIDELITY ADVISOR SERIES VII | 0.14% | 1,208,666 | - | - | Jan 31, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.03% | 18,053 | - | - | Mar 31, 2024 |
| BRIDGEWAY FUNDS INC | 0.03% | 75,000 | -61,250 | -44.95% | Mar 28, 2024 |
| FIDELITY CAPITAL TRUST | 0.02% | 261,100 | -51,900 | -16.58% | Jan 31, 2024 |
| FIDELITY SECURITIES FUND | 0.02% | 1,660,400 | -358,724 | -17.77% | Jan 31, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.02% | 3,754 | - | - | Mar 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.01% | 40,485 | - | - | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.01% | 3,322 | - | - | Mar 31, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.00% | 230,227 | - | - | Feb 29, 2024 |
| VANGUARD INDEX FUNDS | 0.00% | 1,349,186 | -318,152 | -19.08% | Mar 31, 2024 |
| VICTORY PORTFOLIOS | 0.00% | 76,880 | - | - | Mar 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 85,946 | 16,212 | 23.25% | Jan 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 233,501 | 7,243 | 3.20% | Feb 29, 2024 |
| FIDELITY MT VERNON STREET TRUST | 0.00% | 21,708 | - | - | Feb 29, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 1,755 | - | - | Mar 31, 2024 |
| Managed Portfolio Series | 0.00% | 14,078 | - | - | Mar 31, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 11,176 | - | - | Mar 31, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 1,532 | - | - | Mar 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 8,364 | -1,545 | -15.59% | Mar 31, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 8,400 | - | - | Mar 31, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 137,014 | 40,078 | 41.34% | Feb 29, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 1,439 | - | - | Mar 31, 2024 |
| iSHARES TRUST | 0.00% | 1,018,846 | -60,641 | -5.62% | Mar 31, 2024 |
| NORTHERN FUNDS | 0.00% | 8,769 | -7,878 | -47.32% | Mar 28, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 148 | - | - | Mar 31, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 194 | - | - | Dec 31, 2023 |
| VALIC Co I | 0.00% | 11,879 | 2,310 | 24.14% | Feb 29, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 4,719 | - | - | Mar 31, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 34,846 | - | - | Jan 31, 2024 |
| EQ ADVISORS TRUST | 0.00% | 39,423 | - | - | Mar 31, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 900 | - | - | Mar 28, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 3,570 | -3 | -0.08% | Jan 31, 2024 |
| Guggenheim Active Allocation Fund | 0.00% | 161 | - | - | Feb 29, 2024 |
| ALLSPRING MASTER TRUST | 0.00% | 1,678 | - | - | Feb 29, 2024 |
| RYDEX DYNAMIC FUNDS | 0.00% | 96 | - | - | Dec 31, 2023 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 23,748 | - | - | Mar 31, 2024 |
| Dimensional ETF Trust | 0.00% | 9,394 | - | - | Jan 31, 2024 |
| ProFunds | 0.00% | 241 | -18 | -6.95% | Mar 31, 2024 |
| PROSHARES TRUST | 0.00% | 4,535 | 1,328 | 41.41% | Feb 29, 2024 |
| RYDEX VARIABLE TRUST | 0.00% | 13 | - | - | Dec 31, 2023 |
| TIAA-CREF FUNDS | 0.00% | 29,269 | - | - | Jan 31, 2024 |
| SUNAMERICA SERIES TRUST | 0.00% | 3,507 | 682 | 24.14% | Jan 31, 2024 |
| MORGAN STANLEY PATHWAY FUNDS | 0.00% | 903 | - | - | Feb 29, 2024 |
| Brighthouse Funds Trust II | 0.00% | 7,709 | - | - | Mar 31, 2024 |
| ETF Series Solutions | 0.00% | 177 | - | - | Jan 31, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 1,902 | - | - | Jan 31, 2024 |
| LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 18,400 | - | - | Mar 31, 2024 |
| FIDELITY SALEM STREET TRUST | 0.00% | 23,653 | - | - | Mar 31, 2024 |
| PACE SELECT ADVISORS TRUST | 0.00% | 1,800 | - | - | Jan 31, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 7,350 | 6,794 | 1221.94% | Mar 31, 2024 |
| Bridge Builder Trust | 0.00% | 11,540 | - | - | Mar 31, 2024 |
| Blackstone Alternative Investment Funds | 0.00% | 300 | 1,100 | -137.50% | Mar 31, 2024 |
| PACIFIC SELECT FUND | 0.00% | 8,465 | - | - | Mar 31, 2024 |
| MASSMUTUAL SELECT FUNDS | 0.00% | 2,331 | - | - | Dec 31, 2023 |
| Invesco Exchange-Traded Fund Trust II | 0.00% | 674 | - | - | Jan 31, 2024 |
| BlackRock Variable Series Funds, Inc. | 0.00% | 4,479 | - | - | Mar 31, 2024 |
| PRINCIPAL FUNDS, INC. | 0.00% | 3,461 | - | - | Jan 31, 2024 |
| SEI INSTITUTIONAL INVESTMENTS TRUST | 0.00% | 8,300 | - | - | Feb 29, 2024 |
| BLACKROCK FUNDS | 0.00% | 2,181 | - | - | Jan 31, 2024 |
| Advisors' Inner Circle Fund III | 0.00% | 35 | - | - | Jan 31, 2024 |
Ikena Oncology's largest mutual fund holder by % of total assets is "CORNERCAP GROUP OF FUNDS /VA/", owning 11.88K shares, compromising 0.16% of its total assets.
Ikena Oncology Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 19 | -66.07% |
| 31 Mar, 24 | 56 | 3.70% |
| 31 Dec, 23 | 54 | -6.90% |
| 30 Sep, 23 | 58 | 11.54% |
| 30 Jun, 23 | 52 | 33.33% |
| 31 Mar, 23 | 39 | 14.71% |
| 31 Dec, 22 | 34 | -17.07% |
| 30 Sep, 22 | 41 | -2.38% |
| 30 Jun, 22 | 42 | -12.50% |
| 31 Mar, 22 | 48 | -2.04% |
| 31 Dec, 21 | 49 | 25.64% |
| 30 Sep, 21 | 39 | -7.14% |
| 30 Jun, 21 | 42 | 55.56% |
| 31 Mar, 21 | 27 | - |
As of 30 Jun 24, 19 institutions are holding Ikena Oncology's shares, representing a decrease of -66.07% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 7,693,816 | -74.21% |
| 31 Mar, 24 | 29,830,924 | -7.18% |
| 31 Dec, 23 | 32,138,754 | -1.75% |
| 30 Sep, 23 | 32,711,737 | 4.85% |
| 30 Jun, 23 | 31,199,169 | 24.86% |
| 31 Mar, 23 | 24,986,737 | -4.86% |
| 31 Dec, 22 | 26,264,313 | 0.07% |
| 30 Sep, 22 | 26,246,467 | -2.01% |
| 30 Jun, 22 | 26,786,086 | -2.56% |
| 31 Mar, 22 | 27,490,347 | 0.36% |
| 31 Dec, 21 | 27,390,491 | 31.18% |
| 30 Sep, 21 | 20,880,110 | -0.88% |
| 30 Jun, 21 | 21,065,019 | 9.07% |
| 31 Mar, 21 | 19,313,430 | - |
Ikena Oncology (IKNA) has 7.69M shares outstanding as of 30 Jun 24, down -74.21% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 15.94% | 0.31% |
| 31 Mar, 24 | 71.48% | 1.31% |
| 31 Dec, 23 | 73.99% | 1.07% |
| 30 Sep, 23 | 83.25% | 1.12% |
| 30 Jun, 23 | 86.05% | 1.81% |
| 31 Mar, 23 | 68.91% | 1.31% |
| 31 Dec, 22 | 72.58% | 1.38% |
| 30 Sep, 22 | 72.39% | 1.32% |
| 30 Jun, 22 | 74.07% | 1.28% |
| 31 Mar, 22 | 76.20% | 1.31% |
| 31 Dec, 21 | 76.38% | 2.25% |
| 30 Sep, 21 | 58.23% | 1.69% |
| 30 Jun, 21 | 58.75% | 2.02% |
| 31 Mar, 21 | 53.87% | - |
As of 30 Jun 24, Ikena Oncology is held by 15.94% institutional shareholders, representing a 0.31% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 14 | -44.00% |
| 31 Mar, 24 | 25 | -24.24% |
| 31 Dec, 23 | 33 | -2.94% |
| 30 Sep, 23 | 34 | -5.56% |
| 30 Jun, 23 | 36 | 56.52% |
| 31 Mar, 23 | 23 | 91.67% |
| 31 Dec, 22 | 12 | -47.83% |
| 30 Sep, 22 | 23 | 27.78% |
| 30 Jun, 22 | 18 | -18.18% |
| 31 Mar, 22 | 22 | -42.11% |
| 31 Dec, 21 | 38 | 72.73% |
| 30 Sep, 21 | 22 | -26.67% |
| 30 Jun, 21 | 30 | 11.11% |
| 31 Mar, 21 | 27 | - |
14 institutional shareholders have increased their position in IKNA stock as of 30 Jun 24 compared to 25 in the previous quarter (a -44.00% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 3 | -82.35% |
| 31 Mar, 24 | 17 | 41.67% |
| 31 Dec, 23 | 12 | 33.33% |
| 30 Sep, 23 | 9 | 28.57% |
| 30 Jun, 23 | 7 | 16.67% |
| 31 Mar, 23 | 6 | -33.33% |
| 31 Dec, 22 | 9 | 28.57% |
| 30 Sep, 22 | 7 | -61.11% |
| 30 Jun, 22 | 18 | 12.50% |
| 31 Mar, 22 | 16 | 300.00% |
| 31 Dec, 21 | 4 | -50.00% |
| 30 Sep, 21 | 8 | 166.67% |
| 30 Jun, 21 | 3 | - |
| 31 Mar, 21 | - | - |
3 institutional shareholders have reduced their position in IKNA stock as of 30 Jun 24 compared to 17 in the previous quarter (a -82.35% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 19 | -66.07% | 7,693,816 | -74.21% | 15.94% | 0.31% | 14 | -44.00% | 3 | -82.35% |
| 31 Mar, 24 | 56 | 3.70% | 29,830,924 | -7.18% | 71.48% | 1.31% | 25 | -24.24% | 17 | 41.67% |
| 31 Dec, 23 | 54 | -6.90% | 32,138,754 | -1.75% | 73.99% | 1.07% | 33 | -2.94% | 12 | 33.33% |
| 30 Sep, 23 | 58 | 11.54% | 32,711,737 | 4.85% | 83.25% | 1.12% | 34 | -5.56% | 9 | 28.57% |
| 30 Jun, 23 | 52 | 33.33% | 31,199,169 | 24.86% | 86.05% | 1.81% | 36 | 56.52% | 7 | 16.67% |
| 31 Mar, 23 | 39 | 14.71% | 24,986,737 | -4.86% | 68.91% | 1.31% | 23 | 91.67% | 6 | -33.33% |
| 31 Dec, 22 | 34 | -17.07% | 26,264,313 | 0.07% | 72.58% | 1.38% | 12 | -47.83% | 9 | 28.57% |
| 30 Sep, 22 | 41 | -2.38% | 26,246,467 | -2.01% | 72.39% | 1.32% | 23 | 27.78% | 7 | -61.11% |
| 30 Jun, 22 | 42 | -12.50% | 26,786,086 | -2.56% | 74.07% | 1.28% | 18 | -18.18% | 18 | 12.50% |
| 31 Mar, 22 | 48 | -2.04% | 27,490,347 | 0.36% | 76.20% | 1.31% | 22 | -42.11% | 16 | 300.00% |
| 31 Dec, 21 | 49 | 25.64% | 27,390,491 | 31.18% | 76.38% | 2.25% | 38 | 72.73% | 4 | -50.00% |
| 30 Sep, 21 | 39 | -7.14% | 20,880,110 | -0.88% | 58.23% | 1.69% | 22 | -26.67% | 8 | 166.67% |
| 30 Jun, 21 | 42 | 55.56% | 21,065,019 | 9.07% | 58.75% | 2.02% | 30 | 11.11% | 3 | - |
| 31 Mar, 21 | 27 | - | 19,313,430 | - | 53.87% | - | 27 | - | - | - |
Ikena Oncology Insider Shareholders Trades
Open Market Insider Trades
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
All Insider Owners Trades
Ikena Oncology Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q1 2024 | 3 | - | - |
| Q3 2023 | 8 | - | - |
| Q2 2023 | 7 | - | - |
| Q1 2023 | 5 | - | - |
| Q4 2022 | 1 | - | - |
| Q2 2022 | 10 | 9 | 111.11% |
| Q1 2022 | 11 | 9 | 122.22% |
| Q4 2021 | 8 | 12 | 66.67% |
| Q2 2021 | 2 | - | - |
| Q1 2021 | 34 | 48 | 70.83% |
| Q4 2020 | 10 | - | - |
3 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Ikena Oncology's insiders, as of Q1 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q1 2024 | - | - | - |
| Q3 2023 | - | - | - |
| Q2 2023 | - | - | - |
| Q1 2023 | - | - | - |
| Q4 2022 | - | - | - |
| Q2 2022 | 9 | - | - |
| Q1 2022 | - | 1 | - |
| Q4 2021 | - | 7 | - |
| Q2 2021 | - | - | - |
| Q1 2021 | 10 | - | - |
| Q4 2020 | - | - | - |
As of Q1 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Ikena Oncology's stocks.
Ikena Oncology Peer Ownership
| Ticker | Company |
|---|---|
| NRIX | Nurix Therapeutics, Inc. |
| KYMR | Kymera Therapeutics, Inc. |
| DBTX | Decibel Therapeutics, Inc. |
| FHTX | Foghorn Therapeutics Inc. |
| EWTX | Edgewise Therapeutics, Inc. |
| STOK | Stoke Therapeutics, Inc. |
| AVTE | Aerovate Therapeutics, Inc. |
| GLUE | Monte Rosa Therapeutics, Inc. |
| MNOV | MediciNova, Inc. |
| DSGN | Design Therapeutics, Inc. |
| RZLT | Rezolute, Inc. |
| HOWL | Werewolf Therapeutics, Inc. |
| ANEB | Anebulo Pharmaceuticals, Inc. |
| XLO | Xilio Therapeutics, Inc. |
| CELC | Celcuity Inc. |
| STTK | Shattuck Labs, Inc. |
| ELYM | Eliem Therapeutics, Inc. |
IKNA Ownership FAQ
Who Owns Ikena Oncology?
Ikena Oncology is owned by institutional shareholders (15.94%), insiders (7.00%), and public (77.06%). The largest institutional shareholder of Ikena Oncology is ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC (10.40% of total shares) and the top mutual fund owner is CORNERCAP GROUP OF FUNDS /VA/ (0.16% of total shares).
Who are the major institutional shareholders of Ikena Oncology?
Ikena Oncology's major institutional shareholders are ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC, BVF INC/IL, BLUE OWL CAPITAL HOLDINGS LP, ORBIMED ADVISORS LLC, and OMEGA FUND MANAGEMENT, LLC. The top five shareholders own together 40.75% of the company's share outstanding.
How many Ikena Oncology shareholders are there?
As of Jun 2024, there are 19 institutional shareholders of Ikena Oncology.
What percentage of Ikena Oncology is owned by ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC?
ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC owns 5.02M shares of Ikena Oncology, representing 10.40% of the company's total shares outstanding, valued at $8.28M (as of Jun 2024).
What percentage of Ikena Oncology is owned by BVF INC/IL?
As of Jun 2024, BVF INC/IL holds 4.77M shares of Ikena Oncology (IKNA), compromising 9.88% of the company, valued at $7.87M.
What percentage of Ikena Oncology is owned by BLUE OWL CAPITAL HOLDINGS LP?
BLUE OWL CAPITAL HOLDINGS LP is the third largest holder of Ikena Oncology. The company owns 4.09M of the company's shares outstanding (worth $6.75M).